Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$353,732
+$181,221 QoQ
Shares Held
46,119
+202.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in FULC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $353,732 | 46,119 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $172,511 | 15,253 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $172,516 | 48,324 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $965,013 | 102,226 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $638,664 | 94,617 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $699,986 | 96,152 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $693,782 | 85,758 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $612,147 | 124,928 | Principal | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||